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Abstract 
Huntington’s disease is a fatal late-onset genetic illness that causes motor, cognitive and psychiatric 
disorders. Individuals considering genetic testing may benefit from online social support. This study 
investigates how genetic testing is discussed within health forums. 337 messages written by 58 
individuals were analysed using deductive thematic analysis. Discussions examined three themes: 
deciding to be tested (enquiring about symptoms, starting a new family), preparing for the test 
(information seeking, attending appointments), and receiving the results (positive results, negative 
results). Forums can reduce the uncertainty of ambiguous symptoms, and provide ongoing 
personalized support before, during and after a genetic test. 
 
Keywords: Huntington’s disease; online support community; thematic analysis; genetic testing; 
genetic counselling. 
 
Introduction 
Huntington’s disease 
Huntington’s disease (HD) is a fatal, hereditary, degenerative disease caused by an expanded CAG 
repeat on the HTT gene; CAG counts of 6-26 are normal, 27-35 are unstable and could expand in 
future generations, 36-39 may cause HD, and 40+ always cause HD (Dayalu and Albin, 2015; 
Imarisio et al., 2008). It is a relatively rare illness with an estimated prevalence of 6.68 per 100,000 in 
the United Kingdom (Rawlins et al., 2016). Males and females are equally at risk (Frank, 2014), the 
onset of symptoms can occur at any time between infancy and old age (Adams et al., 1988; Roos et 
al., 1991; Walker, 2007), the mean age of onset is 40 years (Roos et al., 1991), and the median illness 
duration is 16.2 years (Roos et al., 1993). When an individual becomes symptomatic, HD is always 
fatal unless the individual dies of an unrelated cause such as cancer before dying of HD (Solberg et 
al., 2018; Sørensen and Fenger, 1992). 
 
Symptoms consist of motor, cognitive and psychiatric disorders (Dayalu and Albin, 2015; Roos, 
2010). Motor disorders include muscle twitching, unsteady gait and difficulty speaking. Cognitive 
disorders affect concentration, memory and attention, and eventually lead to dementia. Psychiatric 
disorders can include depression, anxiety, apathy and obsessive-compulsive behaviours, and 
psychosis in the later stages. 
 
Genetic testing 
Individuals have a 50% risk of inheriting HD if one of their parents has the faulty gene, and those 
with untested parents have a 25% risk if one of their grandparents has the faulty gene (Craufurd, 
1996). Undergoing a genetic test can lead to ethical dilemmas for at-risk individuals, particularly if 
other family members prefer not to know their disease status (Taylor, 2004). For example, a pregnant 
woman might want to have her fetus tested to ensure the next generation is disease-free even though 
her at-risk male partner does not want to know his disease status. If the fetus tests negative then her 
partner’s disease status will remain unknown, but if the fetus tests positive then it will confirm that 
her partner carries the faulty gene. This can lead to difficulties concerning if, when, how and to whom 
the results should be disclosed (Tassicker et al., 2003). 
 
Some at-risk individuals also find it difficult to interpret how factual information about HD applies to 
their own circumstances. For example, Smith et al. (2013) reported that untested individuals who 
already have children are sometimes reluctant to undergo testing because they mistakenly believe that 
a positive test result would increase the probability of each child having the faulty gene. As explained 
above, the children of parents who have tested positive have a 50% risk of inheriting the gene and the 
children of untested parents have a 25% risk. Some untested parents believe that if they undergo 
testing and receive a positive result then this will increase each child’s risk from 25% to 50%, and 
they understandably do not want to do anything that might put their children at increased risk. 
However this misconception arises from a misunderstanding of genetic risk and, in reality, each child 
was born either with or without the faulty gene. Undergoing testing after having children does not 
change the existing genetic status of each child. 
 
For individuals and families who are at-risk of developing HD, there are a number of possible genetic 
tests that can be used. These fall into three broad categories: prenatal tests, predictive tests and 
diagnostic tests. First, prenatal tests are used to determine if a fetus carries the faulty gene, and there 
are a number of options for doing this. Direct testing reveals the disease status of both fetus and parent 
(Simpson and Harper, 2001), exclusion testing determines if a fetus has a low/high risk of HD without 
revealing the parents’ status but could lead to a healthy fetus being terminated if a high risk fetus does 
not have the faulty gene (Simpson and Harper, 2001; Tyler et al., 1990), and pre-implantation genetic 
diagnosis (PGD) transfers disease-free embryos into the womb without revealing the parents’ status 
(Sermon et al., 2002). Second, predictive tests determine if a symptom-free individual has inherited 
the faulty gene that will cause them to develop HD at some point in the future (Baig et al., 2016). 
Third, diagnostic tests are used on individuals who have already developed HD-related symptoms to 
confirm if they have got HD (Craufurd et al., 2015). It is estimated that 0.9% of HD genetic tests are 
prenatal, 62.3% are predictive and 36.8% are diagnostic (Creighton et al., 2003). 
 
The testing process comprises three broad stages: deciding to be tested, preparing for the test, and 
receiving the results. Deciding to be tested is a major decision for those who are at-risk (Taylor, 
2004). Individuals have a right not to know their genetic status (Andorno, 2004; Asscher and Koops, 
2010), a right that is strongly defended by some at-risk individuals (Taylor, 2004). Choosing not to be 
tested lacks the finality of being tested; an untested individual can undergo testing at any future point, 
whereas a tested individual cannot unlearn the knowledge of their disease status (Cox, 2003). 
Deciding to undergo testing is often seen as a moral dilemma where individuals must balance their 
perceived level of risk, the possible consequences of knowing their HD status, and responsibilities 
towards their partner, relatives and the next generation (Cox, 2003; Klitzman et al., 2007; Smith et al., 
2002). 
 
Preparing for the test involves undergoing genetic counselling. This ensures the individual 
understands the molecular genetics of HD, explores their motivations for being tested, and considers 
possible consequences that could arise (Walsh, 1999). Counselling sessions typically provide 
biomedical or educational information rather than exploring the individual’s psychosocial needs 
(Meiser et al., 2008). Counselling requires multiple appointments taking several weeks or months to 
prepare the individual and ensure that follow-up care is provided if they are symptomatic (Hawkins et 
al., 2011). The individual then gives a final confirmation about completing the test, which may 
produce a positive, negative or indeterminate result (Sarangi et al., 2004). 
 
Receiving the results is an important transition point in the life of an at-risk individual (Tibben, 2007). 
Both carriers and non-carriers experience increased distress after receiving their results (Meiser and 
Dunn, 2000), with some individuals maintaining the appearance of coping while struggling to adjust 
to knowing their status (DudokdeWit et al., 1998). They may need to re-evaluate their future plans 
and decide if, when and how to disclose their test results, particularly if they test positive and have 
already got children (Andersson et al., 2012). 
 
Few studies have examined genetic counselling outcomes in terms of helpfulness or satisfaction 
ratings by individuals who are undergoing a HD genetic test. However, a study by Jones and Macleod 
(2014) reported that 93% of individuals undergoing genetic counselling for HD had a ‘good’ or ‘very 
good’ relationship with their counsellor and 84% thought the number of counselling sessions was 
‘about right’, while 32% indicated that the testing process took too long and 11% had difficulty 
engaging with the process. In addition, some individuals reported that they would have appreciated a 
more tailored approach together with access to information resources such as videos of people 
discussing the advantages and disadvantages of testing. Therefore, for some individuals who are 
undergoing the testing process, it appears that their informational and psychosocial needs are not 
being fully met through genetic counselling. Furthermore, there is a lack of ongoing professional 
support for individuals who have undergone testing but are not yet symptomatic (Andersson et al., 
2016). 
 
Taken together, this suggests that many individuals do not have their psychosocial needs adequately 
met in the testing process. Additional sources of information and support may benefit individuals at 
all stages of the testing process, including those who have learned that they are at-risk of HD and 
struggle to correctly interpret how this might apply to their personal circumstances, those who are 
considering a genetic test or undergoing the testing process, and those who have been tested but are 
not yet symptomatic. Consequently, online support communities might be a useful resource for 
individuals during all stages of the HD testing process. This would provide individuals with a way to 
communicate with others who have been through similar testing-related decisions and dilemmas, to 
obtain information, advice and support about all aspects of the testing process. 
 
Online support communities 
Online support communities, herein called forums for brevity, are used to exchange messages with 
others who have experienced similar health-related issues. Forums can be used at any time of the day 
or night to ask questions, obtain information and access support as-and-when required (Coulson and 
Knibb, 2007; Malik and Coulson, 2008). The individual might not know anybody else who is affected 
by HD, and forums provide direct access to others who are in a similar situation and facing similar 
challenges (Coulson et al., 2007). Members often adopt an anonymous online persona (Brady et al., 
2016), which may aid discussing sensitive or distressing topics (Buchanan and Coulson, 2007; 
Coulson and Knibb, 2007). Individuals affected by HD are sometimes reluctant to attend face-to-face 
support groups because they are uncomfortable meeting others with an advanced stage of the illness 
(Dawson et al., 2004), so the anonymity of forums may be particularly beneficial. 
 
Discussions within forums take the form of ‘threads’, where each thread is a self-contained 
conversation consisting of messages written by one or more members (Smedley and Coulson, 2018). 
An individual typically starts a new discussion by posting an initial message, and others post replies 
that are closely tailored to the individual’s needs and circumstances (Coulson et al., 2016; Liang and 
Scammon, 2011). 
 
HD forums can provide a wide range of information, advice and support (Coulson et al., 2007). 
Individuals who are considering a HD genetic test, undergoing genetic counselling, or adjusting to 
receiving a positive or negative test result may benefit from the tailored assistance provided through 
forums, but little is known about how HD genetic testing is discussed within forums. Further research 
is needed to understand how forums can make a positive contribution to the wellbeing of individuals 
affected by HD, and to also provide valuable information to healthcare professionals. 
 
Aims 
The aim of this study was to investigate how the process of genetic testing is discussed within HD 
forums. 
 
Methods 
Data collection 
Data was analysed from the asynchronous forum of a UK-based organisation supporting individuals 
affected by HD. Their forum provided multiple discussion boards covering various aspects of living 
with HD, including a dedicated board for testing-related issues. This was used by at-risk individuals 
who are considering being tested, those undergoing testing, and members who have previously been 
tested. The researchers selected this specific forum as a data source because they were already 
familiar with the forum and they had used it in previous research. 
 
All messages posted on the testing board during the 13-month period from April 2012 to May 2013 
were selected for analysis, producing an initial dataset of 43 threads (371 messages). Off-topic threads 
not directly related to genetic testing were excluded, leading to the removal of 6 threads (34 
messages). The final dataset comprised 37 threads (337 messages). Threads were downloaded and 
saved reproducing each message verbatim including the original formatting, layout and emoticons 
(Smedley and Coulson, 2018). The analysis was carried out immediately after data collection was 
completed and an initial draft was written straight away, but time constraints on other projects meant 
that the paper was not prepared for publication until 2018. 
 
Participants 
58 unique usernames were identified in the dataset. Demographic information was limited because 
forum members often maintain an anonymous online persona (Brady et al., 2016), however some 
information was obtained by examining the content of their messages. Gender was identified for 43 
participants (11 males, 32 females). Health status was identified for 48 participants (35 individuals 
were diagnosed/at-risk of HD, 13 were the partner of somebody diagnosed/at-risk). 
 
Analysis 
Messages were analysed using deductive thematic analysis (Braun and Clarke, 2006). Thematic 
analysis was used because this technique examines the patterns (or themes) that are present within 
textual data, and a deductive approach was employed to analyse the data in the context of three 
aspects of the testing process: deciding to be tested, preparing for the test, and receiving the results. 
Both authors have extensive experience in conducting this type of analysis with online data. First, 
each thread was read multiple times to gain familiarity with the data and identify the broad discussion 
topics related to these themes within that thread. Initial ideas and observations were noted during this 
stage. Second, constant comparison was used to refine and develop these notes by moving back and 
forth across the dataset comparing threads that discussed these issues. After further discussion, both 
authors identified illustrative extracts and reviewed the themes for coherence. It is unclear whether 
data saturation was achieved. It can be difficult to achieve data saturation when analysing forum 
messages because there is always a possibility that downloading more messages may have yielded 
additional insights (Im and Chee, 2006). 
 
Ethical considerations 
Ethical approval for this study was granted by the University of Nottingham, and the study complied 
with British Psychological Society guidelines for internet-mediated research (British Psychological 
Society, 2017). 
 
Informed consent and anonymity can pose ethical dilemmas in forum studies (Smedley and Coulson, 
2018). Consent requests can trigger feelings of anger and distrust among members (Eysenbach and 
Till, 2001; Hudson and Bruckman, 2004), and some members may be impossible to contact or 
reluctant to reveal personal information needed for consent (Roberts, 2015). Consequently data was 
collected from a publically-viewable forum where anybody can read messages without needing to 
register or obtain a password. It is sometimes unclear whether the members of a public forum regard it 
as being a public or private place (Bond et al., 2013; Lomborg, 2013), however using a public forum 
removed the need to obtain consent because attempting to obtain consent may have caused more harm 
than the protection it is intended to provide (Robinson, 2001). In addition, the use of public domain 
data sources, such as the identified forum, is considered acceptable by the British Psychological 
Society provided appropriate safeguards are put in place to ensure that the forum is not named and no 
personally identifiable information is reported (British Psychological Society, 2017). Therefore, in 
order to ensure the anonymity of forum members whose postings had been included in our dataset, we 
paraphrased extracts such that the original meaning was retained but the quote was not traceable to the 
originating forum (Roberts, 2015). 
 
Results 
Three aspects of the HD testing process were examined: deciding to be tested, preparing for the test, 
and receiving the results. 
 
Aspect 1: Deciding to be tested 
Common initiating events for considering a HD genetic test were noticing symptoms that might be 
HD-related and wanting to start a family. 
 
Enquiring about symptoms 
There were several threads where at-risk individuals described symptoms they were currently 
experiencing, and enquired if this might indicate they have inherited the faulty gene. The following 
quote is a typical example of this type of enquiry: 
My mother had eye twitches for many years before developing full-blown HD. I have recently 
noticed twitches in my eyes and fingers, particularly when I am relaxed, reading or watching 
television. I am concerned it might mean I have got HD. Should I get tested? 
 
Replies to these messages were broadly grouped into two subcategories. In the first subcategory, 
individuals responded by relating the original query to their own concerns and experiences. 
Sometimes others would comment that they had joined the forum because they too were worried 
about symptoms (“I joined because I had exactly the same concerns as you”). In-groups and out-
groups were occasionally used to emphasize these shared concerns and distinguish them from the 
experiences of those who are not at-risk (“Outsiders will never understand how stressful it is worrying 
about symptoms and struggling with the guilt that I may have passed HD on to my children, while 
simultaneously feeling too scared to get tested”). More commonly, respondents talked about their own 
symptoms and, where possible, they tried to compare those symptoms with what their affected parent 
experienced when they became symptomatic (“I wish I could remember the symptoms my mother had 
when she first developed HD. I get twitches, stumble and trip over things. Is it nothing, or could I 
have HD?”). 
 
The second subcategory of reply provided factual and educational information about symptoms. 
Individuals often explained that it is normal for at-risk individuals to worry about symptoms 
(“Symptom hunting is common among people who are at-risk, I often do it too”). They discussed the 
age when individuals typically become symptomatic and used this to assess whether their symptoms 
were likely to be caused by HD (“Your mother was diagnosed a few years ago and you are only 
thirty, so it will be a long time before you develop any symptoms”). There were frequent discussions 
about alternative explanations for what might be causing their symptoms (“Many different things 
could cause the symptoms you described. Just feeling anxious about HD could be causing your 
twitches. Being tested is the only way to be certain”). 
 
Starting a new family 
Another common reason for deciding whether to be tested was starting a family. Discussions on this 
topic were grouped into two subcategories: unplanned pregnancies and family planning. 
 
The first subcategory was concerned with unplanned pregnancies. Threads would typically begin with 
an individual discovering that they are pregnant and describing their emotions or asking for advice, as 
illustrated by the following quote: 
I have just found out that I am 10 weeks pregnant with my first child. My partner immediately 
got tested and has just received a positive result for HD. We have arranged a CVS test but I 
feel petrified about what might happen next… 
 
Replies to this form of enquiry would explain the full range of available options. These included 
leaving things to chance and carrying the baby regardless (“I don’t want to know my status and I don’t 
believe in abortions, so we let nature decide”) and having the fetus tested (“For us, testing was the 
only option. We would prefer to be childless than inflict HD on another generation”). Respondents 
emphasized how important it was for each individual to make their own decision about testing and 
what to do if the results are positive (“IF the test is positive then YOU alone must decide whether to 
keep it. I don’t have the right answer. Morally it’s a minefield and others may try to sway you, don’t 
let anyone tell you what to do”). In the thread quoted above the original message contributor had 
already decided to have the fetus tested, which prompted several messages offering emotional support 
(“I’m sorry to hear what you’re going through, it is understandable that you are finding it so 
difficult”). 
 
The second subcategory was concerned with family planning. These discussions typically focussed on 
the queries and dilemmas that individuals faced when considering starting a family, and the 
consequences of having children. The following quote is typical of the quandaries associated with 
this: 
I’m unsure about being tested. An important consideration is the possibility of starting a 
family. If a prenatal test comes back positive then I must have HD too. Would that mean I’m 
using my unborn child to test me as well? Is it irresponsible having children without being 
tested first? 
 
It was evident from reading the replies to such posts that members had a range of responses. Like with 
unplanned pregnancies, some individuals advocated having children without any form of genetic 
testing, arguing that leaving things to chance would give their children the same opportunity to live 
that they themselves had (“we were given the chance to live, so why shouldn’t our children?”). This 
was sometimes accompanied by the hope that better treatments might become available before their 
children become symptomatic (“by the time my children grow up, there might be a way to treat HD or 
even a cure”). For some individuals, this could produce terrible feelings of guilt: 
That is how my mother-in-law felt, believing the cure would be here before it affected her son. 
She now has survivor’s guilt, watching her husband fade away while monitoring her son for 
any tiny hint of HD. 
 
Others described how they had the genetic test in adulthood and discovered that HD had been 
naturally eliminated from their family. Even though older relatives were still affected, they could have 
children without worrying about future generations inheriting the disease (“My sister and I both tested 
negative, so HD has stopped with our father. We are now free but HD still continues with him”). 
 
More frequently, individuals considering starting a family were advised to use pre-implantation 
genetic diagnosis (PGD), where only disease-free embryos are implanted into the womb. This 
technique can still be used if the individual prefers not to know their own disease status (“Having the 
gene doesn’t stop you having children. You can use PGD to ensure the baby is HD-free. Don’t lose 
hope, there is always a workaround”). Genetic testing was seen by some individuals as a way to 
eliminate the faulty HD gene from families without needing a cure (“We are all responsible for the 
next generation. We should all ensure our children are HD free and eliminate the disease without 
needing a cure”). 
 
Aspect 2: Preparing for the test 
After deciding to be tested, members described how they wanted to learn more about genetic testing 
and the genetic counselling that forms a central part of this process. 
 
Information seeking 
A range of information and advice was requested through the messages posted to this board of the HD 
online community. For some, there was a need to ask about practical aspects of the process, such as 
how to initiate a genetic test (“How do I arrange to be tested? Do I just make a GP appointment and 
they contact the required people?”). More commonly, individuals wanted to learn about counselling 
and testing to prepare for their first appointment after being referred to a specialist (“I’m going to the 
genetics department this week for my first appointment. Any advice on what to expect?”). Replies used 
informational support to explain what the counsellor was likely to discuss during these sessions in 
addition to describing the emotional aspects of preparing for the outcome (“The counsellor will 
explain about HD and CAG repeats, and make sure you are planning for the future. It can be 
devastating, people who test negative can still struggle if other relatives test positive. The impact of 
various outcomes is hard to put into words”). 
 
Several messages discussed how long it takes before receiving the results. The number of 
appointments could vary according to personal needs and circumstances, with some individuals 
needing more sessions than others: 
The timeline is roughly this: 1st appointment with genetic counsellor. 2nd appointment 2-3 
months later, with genetic counsellor and a consultant. First blood sample taken and stored. 
3rd appointment with the consultant, second blood sample taken, consent forms signed. 4th 
appointment to get the results. 
 
Some individuals questioned the amount of time needed to go through the testing process and asked 
whether genetic counselling was genuinely necessary (“I know I want to be tested so it seems silly 
having counselling before getting the results. Why can’t I just have the test and get it over with? If the 
results are negative then waiting adds to the stress”). Frustration with the need to attend counselling 
sessions led some individuals to ask if tests can be conducted privately (“Does anyone know if you 
can be privately tested? How much does this cost, and how do you go about it?”). The replies to these 
specific messages typically used informational support to discourage individuals from rushing through 
the testing process, and reminded them to spend time considering how the results might impact upon 
the rest of their lives so that they make the right decision and do not later regret being tested: 
I started off thinking men don’t do counselling. They insisted I attend all the sessions, and 
they were right. It gave me time to think things through and reflect on the implications for my 
family. I did the right thing, after all the results will affect the rest of my life. 
 
Attending appointments 
Several individuals described their feelings about attending their first appointment. It was common to 
report experiencing stress, anxiety and trepidation about being tested (“Went for my first appointment 
this morning, and the anxiety nearly got me. It felt like I was on death row, I was terrified and wanted 
to go home”). Emotional support was often provided in response to these types of messages (“I totally 
understand how you felt, and I hope it all goes well”). Perceptions of the counsellors were nearly 
always positive with individuals describing their appreciation for the information and support that was 
provided (“I was very stressed going to the hospital. After a short wait, the consultant was amazing. 
She was very warm and gave me lots of helpful information”). 
 
Despite the complex emotional dilemmas associated with being tested and preparing for news that 
will affect the rest of their life, some individuals pointed out that being tested does not change 
whether or not they have the faulty gene: 
I wish I could say ‘good luck’ but it isn’t about luck. If you have the gene then you were born 
with it. It’s a part of you that cannot be changed. The only thing that will change is knowing 
about it. 
 
Aspect 3: Receiving the results 
The anxiety and emotional strain of receiving the test results was evident across many of the messages 
posted. These messages illustrated the complexities around ‘making sense’ of the outcome and what it 
might mean for individuals, couples and families. 
 
A number of individuals described the emotional impact of waiting to receive their test results. This 
appeared to be a particularly stressful time, with individuals preparing themselves for a possible 
positive result (“My results are due tomorrow. I’m struggling with nerves, and my arms are shaking 
now that the answer is almost here. I’m preparing for the worst possible outcome”). Replies used 
informational support to provide useful suggestions to prepare for receiving their results, to help 
individuals prepare themselves for what could be potentially life-changing information (“Take time off 
work both before and after getting the results, and consider going away to keep yourself busy. Make 
sure you have the support that you need. Sleeping pills may help with nerves”). Other replies used 
emotional support to provide encouragement during what was an inherently stressful time (“Good 
luck, we’re all thinking of you. Tell us how it goes”). 
 
Positive results 
Each individual responded differently to receiving their results. For some, a positive result came as a 
devastating blow despite all the preparations (“Believe me, learning I was positive felt like being 
slammed into a wall. I thought I was prepared but I wasn’t”). Others felt ambivalent or relieved after 
receiving a positive result because it explained their symptoms (“The consultant did a neurological 
test at the same time as taking the blood sample, and said it was likely to be HD. It was a relief to 
finally know what was wrong. The uncertainty was worse”). Years after receiving a positive result, 
some individuals still struggled to cope but nonetheless explained the importance of maintaining an 
optimistic outlook and continuing to live in a meaningful way, as demonstrated by this quote: 
I wouldn’t say I was coping but I’m still symptom free. I go to work, pay the rent, and try to 
make the best of my circumstances. You have to find a way to live positively. It isn’t a death 
sentence, and there are worse illnesses to have. 
 
Some individuals underwent prenatal testing following an unexpected pregnancy. Unfortunately, this 
did not always produce the results that members hoped for (“The CVS produced a positive result so 
I’m booked in for a surgical termination. Words cannot describe how I now feel”). When this 
happened, respondents would again provide emotional support (“My thoughts are with you. Keep 
trying, and one day you will have a healthy baby”). 
 
Negative results 
Some individuals who tested negative described feelings of shock and disbelief upon learning they do 
not have the faulty gene (“I can’t believe it! My results came back negative with a CAG count of 18. I 
was convinced it would be positive because my brother’s results were negative”). Others responded 
with relief (“Just got my results, my CAG count is 16. It feels like a dream, and a big relief after all 
the anxiety”). Those with a negative result still sometimes faced ongoing challenges, particularly if 
others in their family were at-risk or tested positive. HD was still part of their lives, and some 
individuals felt a responsibility to encourage other family members to be tested (“My results were 
negative but my sister came back positive. What happens next? I had a lucky escape but HD is still 
part of my life, and I need to convince others to get tested as well”). 
 
A small number of messages questioned the reliability of test results. One individual said that her 
husband had tested negative and he now wondered if his results could be wrong (“My husband’s 
results came back negative in [year]. His mother is still symptom-free, yet he is concerned that the 
results might have been wrong. How accurate is the test?”). Others replied to these messages by 
providing assurance about the accuracy of the results (“At my hospital, they took two blood samples 
and needed four signatures verifying the results. It is very unlikely that his results were wrong, and 
his CAG count is well below the threshold for HD”). 
 
Discussion 
This study investigated how HD genetic testing is discussed within online support forums, examining 
three key aspects of the process: deciding to be tested, preparing for the test, and receiving the results. 
 The first aspect, deciding to be tested, was associated with wanting to know if a symptom might be an 
early sign of the onset of HD, and wanting to start a family. Enquiring about symptoms was common 
within the forum, with members describing ambiguous symptoms that may or may not be 
representative of HD. This appeared to put members in a state of uncertainty, consistent with 
uncertainty in illness theory (Mishel, 1990). Research indicates that health uncertainty can have a 
range of causes including experiencing ambiguous symptoms that could be associated with multiple 
underlying illnesses, and a lack of knowledge regarding the probable onset and development of a 
health condition (Han et al., 2011). Uncertainty is strongly and positively associated with anxiety 
(Kuang and Wilson, 2017), indicating that greater levels of uncertainty lead to heightened anxiety. In 
the present study, individuals may have experienced health uncertainty due to not knowing their 
genetic status combined with the ambiguous nature of symptoms that might potentially be indicative 
of HD. The perception that HD is a fatal illness may have further increased the resulting feelings of 
anxiety. 
 
The lack of treatment options for HD combined with a high probability of mental deterioration can 
give HD a psychological stigma that may lead some individuals to carefully conceal their status from 
others (Quaid et al., 2008). The anonymous online personas associated with forums (Brady et al., 
2016) may make it easier to discuss challenging, sensitive or stigmatised topics that individuals might 
not otherwise be able to talk about (Coulson and Knibb, 2007; White and Dorman, 2001). Taken 
together, health uncertainty combined with psychological stigma may have prompted individuals to 
join the forum to seek further guidance, information and support. Members in this situation discussed 
whether it was the right time to consider undergoing genetic testing to reduce or eliminate this 
uncertainty by confirming if they have got the faulty gene. 
 
Wanting to start a family involved discussing a diverse range of issues with a particular focus on 
prenatal and predictive testing, whether to prevent their children from inheriting the faulty gene or 
leave things to chance, and the dilemmas and feelings of guilt arising from these decisions. Similar 
findings were obtained by a study interviewing at-risk individuals about reproductive decisions, where 
participants talked about having children, reproductive options such as PGD, and feelings of guilt 
(Klitzman et al., 2007). This suggests the current results may broadly reflect the reproductive 
concerns faced by individuals affected by HD. Whether or not individuals undergo genetic testing, 
they subsequently tend to feel happy with their decision (Nance, 2017). When at-risk individuals 
consider starting a family, forums may be an important source of information and guidance to help 
with reproductive decisions. Indeed, none of the messages indicated that becoming a member had 
negatively impacted their wellbeing or that they had found the forum unhelpful. That said, it is 
possible that some members found the forum unhelpful but those individuals may have been less 
likely to post messages about their experiences (Amichai-Hamburger et al., 2016). For individuals 
who are comfortable with being tested despite the emotional dilemmas that can arise, using genetic 
testing to aid reproductive decisions was sometimes perceived as an effective strategy for eradicating 
the faulty gene from future generations of their family (Turner and Willoughby, 1990). 
 
The second and third aspects of testing were preparing for the test and receiving the results. 
Individuals discussed the testing process, what happens during counselling sessions, and expressed 
their emotions about being tested. Replies used informational support to provide factual information 
and advice, and emotional support when discussing their fears and anxieties. Many threads described 
the experience of receiving their results, with both positive and negative test results having long-term 
consequences. Informational support was used to provide advice and coping strategies when preparing 
for the results, while emotional support helped them adjust to knowing if they had the faulty gene. 
 
These results are consistent with optimal matching theory (Cutrona and Suhr, 1994). This theory 
argues that individuals will find different types of social support effective depending on what kind of 
health-related problem they are experiencing, the controllability of that problem, and how it impacts 
on other important aspects of their life such as personal or professional relationships. In particular, 
optimal matching theory distinguishes between two support categories: action-facilitating support 
such as informational support helps the individual by providing the resources needed to solve or 
overcome a problem, while nurturant support such as emotional support helps them to cope with their 
circumstances by providing reassurance and reducing stress. 
 
Informational and emotional support were both commonly used in the forum, supporting the findings 
of other studies investigating both HD forums and optimal matching theory. Coulson et al. (2007) 
examined the prevalence of these support categories within a HD forum, reporting that informational 
support was present in 56.2% of messages and emotional support was present in 51.9% of messages. 
Similarly, in their meta-analysis looking at support types in relation to different health-related 
stressors, Rains et al. (2015) found that nurturant support is associated with health conditions that are 
likely to impact on personal relationships and conditions that might potentially result in death, while 
informational support is common in conditions with a longer duration. HD is a late-onset disorder 
(Roos et al., 1991) that can adversely affect relationships (Andersson et al., 2016) and culminates in 
death (Solberg et al., 2018), thus offering an explanation as to the types of support that were observed 
in the present study. 
 
The long-term availability of support through forums appears to be especially important. Professional 
support is typically only provided to individuals while they are undergoing genetic counselling to 
prepare for being tested, whereas online peer support is available through all stages of the testing 
process and beyond. Forums provide access to information and support to help individuals decide 
whether to undergo testing, they act as a supplemental source of support while preparing for the test, 
and they are a source of long-term help that individuals can continue to access after receiving their 
results. Individuals who continue using the forum may derive additional benefits as a consequence of 
providing help to other members, such as those who have not yet undergone testing. This is consistent 
with the helper-therapy principle, which argues that individuals who help others also help themselves 
by taking on valued social roles, developing their own coping skills and abilities, and focusing on 
other people’s concerns instead of dwelling upon their own issues (Riessman, 1997). 
 
Forum replies were personalised to each individual’s unique needs (Coulson et al., 2016). This may 
be particularly beneficial to individuals who would like additional information and support that is 
more closely tailored to their own circumstances (Jones and Macleod, 2014). Genetic counselling is 
provided by healthcare professionals who might not have personally experienced HD, whereas online 
support is provided by individuals who have experienced similar challenges and difficulties (Coulson 
et al., 2007). Interacting with and receiving support from peers who have been through similar 
experiences may be particularly helpful because they often have a similar perspective about the illness 
and can relate to what a person is experiencing (Coulson, 2013; Coulson et al., 2016). 
 
Many forums are used by laypeople and their carers for peer support, however some forums are also 
used by healthcare professionals (O'Grady et al., 2010; van der Eijk et al., 2013). Few studies have 
examined self-help forums that are used by both peers and healthcare professionals, but it appears that 
individuals derive additional benefits when healthcare professionals join forums. For example, Vennik 
et al. (2014) reported that individuals appreciated receiving ‘expert knowledge’ from professionals 
alongside the ‘experiential knowledge’ provided by peers. Experts provided specialist information 
about medications, treatment options and new findings, while peers discussed ideas and suggestions 
that might not be evidence-based but which other individuals found helpful for self-managing their 
health condition. Having both sources of information available side-by-side helped individuals to 
achieve a deeper understanding of their personal health. 
 
Healthcare professionals are sometimes reluctant to engage with forums and other online resources. 
For example they might be worried about loss-of-control in consultations or feel that their 
professional expertise is undervalued (Ahluwalia et al., 2010), or they might not have the time, 
knowledge, training or computer skills required to recommend or use forums (Anderson, 2008). 
Despite such reservations, it appears that there is potential for healthcare professionals to play a range 
of important roles in forums. They could make face-to-face patients aware of the potential benefits of 
using forums, join forums themselves to provide expert knowledge, and also use forums to assess 
whether current clinical practice guidelines are successfully addressing the psychosocial needs of 
patients. 
 
There are a number of limitations to this study which should be considered. Firstly, the present study 
analysed all relevant messages posted within a 13-month period. However, this yielded only 337 
messages generated by 58 unique community members. As a consequence of this modest dataset, the 
extent to which the findings can be generalised may be limited. Secondly, whilst males and females 
have an equal risk of HD (Frank, 2014) and females are slightly more likely to undergo predictive 
testing (Baig et al., 2016) the data used in this study were from predominantly females, which is 
consistent with the findings of other forum studies (Coulson et al., 2016; Smedley and Coulson, 
2017). The reasons for this gender imbalance are not clearly understood. It may be an 
oversimplification to assume that females are more sensitive to health issues and/or more likely to 
adopt caring roles (Manierre, 2015), so further research is needed to fully understand the underlying 
cause of these gender differences. 
 
Future research could build upon these findings by examining the following issues. First, these results 
indicate that forum membership may play an important role in all aspects of the HD genetic testing 
process, but little is known about how forum participation contributes to decision making. Qualitative 
research could be used to investigate this area in greater detail, perhaps by adapting a longitudinal 
case study design that follows individuals through all aspects of the testing process and beyond. 
Second, it is unknown how the experience of undergoing genetic testing differs among individuals 
who use forums compared with those who do not use them. For example, individuals who receive 
additional support from online forums may fare better, worse or just the same as those who do not use 
forums. Third, there is an urgent need for research examining the factual accuracy of postings within 
HD forums. If individuals are using forums to assist them with genetic testing decisions, aided by 
postings that may or may not contain potentially misleading information, then this may be of concern 
for both individuals and healthcare professionals. 
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